Multidisciplinary Evaluation of Accelerated Aging in HIV-1 Infection
HIV-1 感染加速衰老的多学科评估
基本信息
- 批准号:9271038
- 负责人:
- 金额:$ 22.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-01 至 2019-05-31
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAdultAdverse effectsAgeAgingAllelesAnti-Retroviral AgentsApplications GrantsAutoimmune DiseasesAutoimmune ProcessAutoimmunityBiologicalBiological AssayC-reactive proteinCCL2 geneCD28 geneCellsCessation of lifeCharacteristicsChronicChronic DiseaseChronologyClinicalComorbidityCytotoxic T-Lymphocyte-Associated Protein 4DataData AnalysesData SetDeteriorationDiseaseDrug toxicityEconomicsElderlyEnzyme-Linked Immunosorbent AssayEpidemicEvaluationFlow CytometryGenderGeneral PopulationGeneticGenetic DriftGenomicsGenotypeGoalsHIVHIV InfectionsHIV-1HLA AntigensHeritabilityHeterogeneityImmuneImmunityImmunogeneticsImmunologic MarkersImmunologicsImmunologyImmunosuppressive AgentsIndividualInfectionInflammationInflammatoryInterleukin-18InterventionLife StyleLong-Term EffectsLymphocyteMediatingMetabolismMolecularMolecular ProfilingMonitorMorbidity - disease rateOrganOutcomePathogenesisPatternPeripheralPersonsPlasmaPopulationPremature aging syndromePsoriasisRANTESRecording of previous eventsRegimenResearchResidual stateSamplingSingle Nucleotide PolymorphismSmokingSubgroupSubstance abuse problemSurvivorsTestingThe Multicenter AIDS Cohort StudyTimeTranslational ResearchVariantVirusVisitWomanWomen’s Interagency HIV StudyYouthage groupantiretroviral therapychemokineco-infectioncohortcytokinedemographicsdesignexhaustionfollow-upfundamental researchgenetic profilinggenetic selectiongenetic variantgenome wide association studyhuman genomicsimmune activationimmune healthimmunopathologyimmunosenescenceindexingmenmicrobialmiddle agemonocytemortalitymultidisciplinarysenescencesocialsuccesstoolunhealthy lifestyle
项目摘要
PROJECT SUMMARY
Global access to combination antiretroviral therapy (cART) has turned HIV infection from a death sentence to a
manageable, chronic illness in which co-infections and comorbidities become increasingly important. In
particular, persons living with HIV-1 infection (PLWH) are prone to suffering from accelerated/premature aging
(A/PA) that exacerbates non-AIDS morbidity and mortality, often regardless of social and economic status.
Although the potential culprits can range from unhealthy lifestyle and adverse effects of antiretrovirals to
chronic inflammation/immune activation (residual HIV replication or microbial translocation) and deterioration of
immunologic health, including immune senescence and immune exhaustion, our own research has uncovered
clear evidence that A/PA is a highly heterogeneous outcome because many PLWH have been subjected to a
genetic selection before 1996 (the dawn of cART era). In other words, heritable genetic factors that
differentially mediate metabolism, infection, immunity, and immunopathology (e.g., autoimmune disorders) can
obscure the interpretation of A/PA. Accordingly, we aim to study immunogenetic profiles and immunologic
features that may readily distinguish PLWH subgroups from age- and gender-matched control (HIV-) subjects
from the general population. Specifically, Aim 1 will examine the distribution of biologically and functionally
relevant genetic variants in 526 (342 HIV+ and 184 HIV-) youth and 2,028 (652 HIV+ and 1,376 HIV-) adults,
with a focus on single nucleotide polymorphisms (SNPs) and human leukocyte antigen (HLA) variants that are
known or predicted to be causal factors for 21 autoimmune conditions, including psoriasis (a common
inflammatory disease) that is expected to rise in PLWH populations. Genotyping data from youth and adult
populations (2,554 total subjects) will test a central hypothesis that PLWH who managed to do well
without cART are genetically distinct, especially in terms of immunogenetic profiles that protect them
from HIV pathogenesis, while predisposing them to autoimmune disorders. Aim 2 will further examine
trajectories of immunologic health in PLWH youth and adults stratified by favorable and unfavorable genetic
profiles, primarily through analyses of inflammatory cytokines, chemokines, and cellular markers of lymphocyte
and monocyte activation or exhaustion. Overall, these multidisciplinary studies will open new avenues for
translational research on autoimmunity and HIV-related A/PA in the highly heterogeneous PLWH populations.
项目概要
全球范围内获得联合抗逆转录病毒疗法 (cART) 已将艾滋病毒感染从死刑变成了绝症
可控制的慢性疾病,其中合并感染和合并症变得越来越重要。在
特别是,HIV-1感染者(PLWH)容易加速/过早衰老
(A/PA) 加剧了非艾滋病发病率和死亡率,通常与社会和经济状况无关。
尽管潜在的罪魁祸首可能包括不健康的生活方式和抗逆转录病毒药物的副作用,
慢性炎症/免疫激活(残留的艾滋病毒复制或微生物易位)和恶化
我们自己的研究发现,免疫健康,包括免疫衰老和免疫衰竭
明确的证据表明,A/PA 是一个高度异质性的结果,因为许多 PLWH 都受到了
1996年之前的基因选择(cART时代的黎明)。换句话说,可遗传的遗传因素
差异介导代谢、感染、免疫和免疫病理学(例如自身免疫性疾病)可以
模糊了 A/PA 的解释。因此,我们的目标是研究免疫遗传学谱和免疫学
可以轻松区分 PLWH 亚组与年龄和性别匹配对照 (HIV-) 受试者的特征
来自一般人群。具体来说,目标 1 将检查生物学和功能上的分布
526 名(342 名 HIV+ 和 184 名 HIV-)青少年和 2,028 名(652 名 HIV+ 和 1,376 名 HIV-)成年人的相关遗传变异,
重点关注单核苷酸多态性 (SNP) 和人类白细胞抗原 (HLA) 变异
已知或预测为 21 种自身免疫性疾病的致病因素,其中包括牛皮癣(一种常见的
炎症性疾病),预计感染者和感染者人数将会增加。来自青少年和成人的基因分型数据
人群(总共 2,554 名受试者)将检验一个中心假设,即表现良好的 PLWH
没有 cART 的人在遗传上是不同的,特别是在保护他们的免疫遗传特征方面
免受艾滋病毒发病机制的影响,同时使他们易患自身免疫性疾病。目标2将进一步检验
按有利和不利遗传分层的感染者青少年和成人的免疫健康轨迹
概况,主要通过分析炎症细胞因子、趋化因子和淋巴细胞的细胞标记物
和单核细胞激活或耗竭。总体而言,这些多学科研究将为
在高度异质性的 PLWH 人群中进行自身免疫和 HIV 相关 A/PA 的转化研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jianming Tang其他文献
Jianming Tang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jianming Tang', 18)}}的其他基金
Heterogeneity in Cytokine Responses to HIV-1 Infection
HIV-1 感染的细胞因子反应的异质性
- 批准号:
8115523 - 财政年份:2010
- 资助金额:
$ 22.28万 - 项目类别:
Host Genetic Epidemiology in HIV-1-Discordant African Couples and Other Cohorts
HIV-1 不一致的非洲夫妇和其他群体的宿主遗传流行病学
- 批准号:
8070218 - 财政年份:2010
- 资助金额:
$ 22.28万 - 项目类别:
Heterogeneity in Cytokine Responses to HIV-1 Infection
HIV-1 感染的细胞因子反应的异质性
- 批准号:
7919719 - 财政年份:2009
- 资助金额:
$ 22.28万 - 项目类别:
Host Genetic Epidemiology in HIV-1-Discordant African Couples and Other Cohorts
HIV-1 不一致的非洲夫妇和其他群体的宿主遗传流行病学
- 批准号:
8260329 - 财政年份:2008
- 资助金额:
$ 22.28万 - 项目类别:
Host Genetic Epidemiology in HIV-1-Discordant African Couples and Other Cohorts
HIV-1 不一致的非洲夫妇和其他群体的宿主遗传流行病学
- 批准号:
8073630 - 财政年份:2008
- 资助金额:
$ 22.28万 - 项目类别:
Genetic Epidemiology of Adult Brain Cancer: A Follow-up Study
成人脑癌的遗传流行病学:一项后续研究
- 批准号:
7387002 - 财政年份:2007
- 资助金额:
$ 22.28万 - 项目类别:
Heterogeneity in Cytokine Responses to HIV-1 Infection
HIV-1 感染的细胞因子反应的异质性
- 批准号:
7891262 - 财政年份:2007
- 资助金额:
$ 22.28万 - 项目类别:
Genetic Epidemiology of Adult Brain Cancer: A Follow-up Study
成人脑癌的遗传流行病学:一项后续研究
- 批准号:
7500868 - 财政年份:2007
- 资助金额:
$ 22.28万 - 项目类别:
Heterogeneity in Cytokine Responses to HIV-1 Infection
HIV-1 感染的细胞因子反应的异质性
- 批准号:
7488548 - 财政年份:2007
- 资助金额:
$ 22.28万 - 项目类别:
Heterogeneity in Cytokine Responses to HIV-1 Infection
HIV-1 感染的细胞因子反应的异质性
- 批准号:
7339125 - 财政年份:2007
- 资助金额:
$ 22.28万 - 项目类别:
相似国自然基金
单核细胞产生S100A8/A9放大中性粒细胞炎症反应调控成人Still病发病及病情演变的机制研究
- 批准号:82373465
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SERPINF1/SRSF6/B7-H3信号通路在成人B-ALL免疫逃逸中的作用及机制研究
- 批准号:82300208
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于动态信息的深度学习辅助设计成人脊柱畸形手术方案的研究
- 批准号:82372499
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
The University of Miami AIDS Research Center on Mental Health and HIV/AIDS - Center for HIV & Research in Mental Health (CHARM) Research Core & MHD-CE
迈阿密大学艾滋病心理健康和艾滋病毒/艾滋病研究中心 - Center for HIV
- 批准号:
10686545 - 财政年份:2023
- 资助金额:
$ 22.28万 - 项目类别:
Bridges-Round 2: Evaluating the Long-term Impact of a Family Economic Empowerment Intervention on HIV Risk Prevention and Care Continuum Outcomes among Orphaned Youth Transitioning to Young Adulthood
Bridges-Round 2:评估家庭经济赋权干预措施对过渡到青年时期的孤儿青少年的艾滋病毒风险预防和护理连续结果的长期影响
- 批准号:
10593954 - 财政年份:2022
- 资助金额:
$ 22.28万 - 项目类别:
Bridges-Round 2: Evaluating the Long-term Impact of a Family Economic Empowerment Intervention on HIV Risk Prevention and Care Continuum Outcomes among Orphaned Youth Transitioning to Young Adulthood
Bridges-Round 2:评估家庭经济赋权干预措施对过渡到青年时期的孤儿青少年的艾滋病毒风险预防和护理连续结果的长期影响
- 批准号:
10405349 - 财政年份:2022
- 资助金额:
$ 22.28万 - 项目类别:
Quantifying Sex-and-Age-Related Differences in Antiretroviral Exposure and Adverse Effects in the MACS/WIHS Combined Cohort Study
MACS/WIHS 联合队列研究中抗逆转录病毒药物暴露和不良反应的性别和年龄相关差异的量化
- 批准号:
10390354 - 财政年份:2021
- 资助金额:
$ 22.28万 - 项目类别:
Addressing the burden of untreated HIV in cancer patients in sub-Saharan Africa: feasibility and planning for a pragmatic clinical trial
解决撒哈拉以南非洲癌症患者未经治疗的艾滋病毒负担:实用临床试验的可行性和规划
- 批准号:
10252626 - 财政年份:2021
- 资助金额:
$ 22.28万 - 项目类别: